BR9706360A - Compostos de n-benzilpiperazina novos um processo para sua preparação e para as composições farmacêuticas que os contêm - Google Patents
Compostos de n-benzilpiperazina novos um processo para sua preparação e para as composições farmacêuticas que os contêmInfo
- Publication number
- BR9706360A BR9706360A BR9706360A BR9706360A BR9706360A BR 9706360 A BR9706360 A BR 9706360A BR 9706360 A BR9706360 A BR 9706360A BR 9706360 A BR9706360 A BR 9706360A BR 9706360 A BR9706360 A BR 9706360A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- optionally substituted
- alkoxy
- new
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9615415A FR2757164B1 (fr) | 1996-12-16 | 1996-12-16 | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9706360A true BR9706360A (pt) | 1999-06-01 |
Family
ID=9498696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9706360A BR9706360A (pt) | 1996-12-16 | 1997-12-16 | Compostos de n-benzilpiperazina novos um processo para sua preparação e para as composições farmacêuticas que os contêm |
Country Status (19)
Country | Link |
---|---|
US (1) | US5849745A (pt) |
EP (1) | EP0847999B1 (pt) |
JP (1) | JPH10175967A (pt) |
CN (1) | CN1192436A (pt) |
AT (1) | ATE199902T1 (pt) |
AU (1) | AU720803B2 (pt) |
BR (1) | BR9706360A (pt) |
CA (1) | CA2225780C (pt) |
DE (1) | DE69704329T2 (pt) |
DK (1) | DK0847999T3 (pt) |
ES (1) | ES2157541T3 (pt) |
FR (1) | FR2757164B1 (pt) |
GR (1) | GR3035855T3 (pt) |
HU (1) | HUP9702481A3 (pt) |
NO (1) | NO975903L (pt) |
NZ (1) | NZ329394A (pt) |
PL (1) | PL323767A1 (pt) |
PT (1) | PT847999E (pt) |
ZA (1) | ZA9711253B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002070456A1 (en) * | 2001-03-01 | 2002-09-12 | Technological Resources Pty Limited | Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal |
FR2827284B1 (fr) * | 2001-07-16 | 2003-10-31 | Servier Lab | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN102993122B (zh) * | 2012-12-24 | 2015-03-04 | 武汉武药制药有限公司 | 盐酸曲美他嗪的合成新路线 |
EP4092013A1 (en) | 2017-06-20 | 2022-11-23 | Imbria Pharmaceuticals, Inc. | Compositions and methods for increasing efficiency of cardiac metabolism |
US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3262852A (en) * | 1966-07-26 | Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same | ||
US2927924A (en) * | 1958-04-03 | 1960-03-08 | Lilly Co Eli | Novel phenethyl-substituted piperazines |
FR805M (pt) * | 1960-06-30 | 1961-09-01 | ||
FR1302958A (fr) * | 1961-03-21 | 1962-09-07 | Science Union & Cie | Préparations des dérivés trialcoxylés de la benzyl-1 pipérazine |
FR1303080A (fr) * | 1961-07-25 | 1962-09-07 | Science Union Et Compagnie Soc | Pipérazines disubstituées |
US5070089A (en) * | 1988-01-26 | 1991-12-03 | Nippon Chemiphar Co., Ltd. | Therapeutic agent for liver disease and piperazine derivatives |
FR2681324B1 (fr) * | 1991-09-18 | 1993-10-29 | Adir Cie | Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant. |
FR2703048B1 (fr) * | 1993-03-24 | 1996-01-05 | Adir | Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
-
1996
- 1996-12-16 FR FR9615415A patent/FR2757164B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-04 AT AT97402934T patent/ATE199902T1/de not_active IP Right Cessation
- 1997-12-04 DE DE69704329T patent/DE69704329T2/de not_active Expired - Fee Related
- 1997-12-04 DK DK97402934T patent/DK0847999T3/da active
- 1997-12-04 PT PT97402934T patent/PT847999E/pt unknown
- 1997-12-04 EP EP97402934A patent/EP0847999B1/fr not_active Expired - Lifetime
- 1997-12-04 ES ES97402934T patent/ES2157541T3/es not_active Expired - Lifetime
- 1997-12-15 NZ NZ329394A patent/NZ329394A/xx unknown
- 1997-12-15 US US08/990,611 patent/US5849745A/en not_active Expired - Fee Related
- 1997-12-15 ZA ZA9711253A patent/ZA9711253B/xx unknown
- 1997-12-15 JP JP9344823A patent/JPH10175967A/ja active Pending
- 1997-12-15 PL PL97323767A patent/PL323767A1/xx unknown
- 1997-12-16 CN CN97107273A patent/CN1192436A/zh active Pending
- 1997-12-16 HU HU9702481A patent/HUP9702481A3/hu unknown
- 1997-12-16 CA CA002225780A patent/CA2225780C/fr not_active Expired - Fee Related
- 1997-12-16 AU AU48422/97A patent/AU720803B2/en not_active Ceased
- 1997-12-16 BR BR9706360A patent/BR9706360A/pt not_active Application Discontinuation
- 1997-12-16 NO NO975903A patent/NO975903L/no not_active Application Discontinuation
-
2001
- 2001-05-11 GR GR20010400707T patent/GR3035855T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU720803B2 (en) | 2000-06-15 |
DE69704329T2 (de) | 2001-09-20 |
NO975903L (no) | 1998-06-17 |
DE69704329D1 (de) | 2001-04-26 |
US5849745A (en) | 1998-12-15 |
FR2757164B1 (fr) | 1999-01-22 |
CN1192436A (zh) | 1998-09-09 |
EP0847999B1 (fr) | 2001-03-21 |
PT847999E (pt) | 2001-08-30 |
GR3035855T3 (en) | 2001-08-31 |
HUP9702481A3 (en) | 1999-03-01 |
ZA9711253B (en) | 1998-06-23 |
CA2225780A1 (fr) | 1998-06-16 |
HU9702481D0 (en) | 1998-03-02 |
CA2225780C (fr) | 2002-11-19 |
FR2757164A1 (fr) | 1998-06-19 |
PL323767A1 (en) | 1998-06-22 |
JPH10175967A (ja) | 1998-06-30 |
ES2157541T3 (es) | 2001-08-16 |
NO975903D0 (no) | 1997-12-16 |
ATE199902T1 (de) | 2001-04-15 |
EP0847999A1 (fr) | 1998-06-17 |
HUP9702481A2 (hu) | 1998-07-28 |
DK0847999T3 (da) | 2001-04-30 |
NZ329394A (en) | 1998-10-28 |
AU4842297A (en) | 1998-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT96145A (pt) | Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem | |
AU4017893A (en) | New 1,4-disubstituted piperazine, a process for their preparation and pharmaceutical compositions containing them | |
PT99775A (pt) | Processo para a preparacao de novos derivados de di-hidroisoquinolina | |
ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ATE302778T1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
AU4616893A (en) | New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them | |
BR9305164A (pt) | Composto, formulação farmacêutica e processo para preparar um composto | |
BR9503536A (pt) | Composto processo para sua preparação seu uso e composição farmacêutica | |
BR9706360A (pt) | Compostos de n-benzilpiperazina novos um processo para sua preparação e para as composições farmacêuticas que os contêm | |
NO960148D0 (no) | Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike | |
LV11689A (lv) | 4-Ú(2-benzotiazolil)metilamino¾-alfa-Ú(3,4-difluorfenoksi)metil¾-1-piperidinetanols | |
BR0106248A (pt) | Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
GR3021736T3 (en) | N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc. | |
AU2001235668A1 (en) | Xanthine derivatives, intermediates and use for treating osteoporosis | |
PT1010698E (pt) | Novos derivados de 1,2-ditiolano processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
ES2149247T3 (es) | Nuevos compuestos de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los incluyen. | |
NO950177D0 (no) | Farmakologisk aktive erivater | |
ES2062214T3 (es) | Derivados de aminooligohidroxi inhibidores de renina. | |
NO972942L (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
ATE258934T1 (de) | Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe | |
BR9908057A (pt) | Derivados de amino antraciclinona | |
DK0826663T3 (da) | Alkynylaminosyrederivater og deres anvendelse som farmaceutiske forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: LES LABORATOIRES SERVIER (FR) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |